Industry
Halozyme Therapeutics Abandons $2.1 Billion Acquisition Bid for Evotec Due to Lack of Engagement
Halozyme Therapeutics, Evotec, acquisition bid, withdrawal, lack of engagement, biotech industry
CSL Behring to Close California R&D Site Amid Shift in Gene Therapy Strategy
CSL Behring, California R&D site closure, ex vivo gene therapy, strategic repositioning, biotech industry trends
RFK Jr.’s HHS Nomination: A Potential Threat to the Biopharma Industry
RFK Jr., HHS nomination, biopharma industry, vaccine skepticism, health policies, Trump administration
Gilead Sciences and Kite Pharma Announce Layoffs, Closure of Seattle and Philadelphia Offices
Gilead Sciences, Kite Pharma, layoffs, office closures, Seattle, Philadelphia, biotech industry, restructuring
Charles River Laboratories Embarks on Restructuring, Closing 15 Smaller Sites Amid Declining Demand for Early Research Services
Charles River Laboratories, restructuring, site closures, declining demand, early research services, cost-cutting measures, biotech industry challenges.
WuXi AppTec Faces Uncertainty Amid BIOSECURE Act, Yet Continues to Secure New Projects
BIOSECURE Act, WuXi AppTec, Biotechnology Industry, U.S. Legislation, Contract Development and Manufacturing Organizations (CDMOs), Biopharma Outsourcing, National Security Concerns
Icon, Irish CRO Giant, Announces Layoffs Following Disappointing Q3 Performance
Icon, layoffs, Q3 performance, Irish CRO, biotech industry
WuXi AppTec and WuXi Biologics Consider Asset Sales Amid BIOSECURE Act Scrutiny
WuXi AppTec, WuXi Biologics, BIOSECURE Act, asset sales, biotech industry, US-China relations
Turnstone Biologics Undergoes Strategic Restructuring with Layoffs and Leadership Changes
Turnstone Biologics, layoffs, leadership changes, strategic restructuring, biotech industry
Relay Therapeutics Announces Additional Layoffs to Achieve $50M Annual Savings
Relay Therapeutics, layoffs, cost-cutting, biotech industry, workforce reduction